DK0751785T4 - Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf - Google Patents

Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf

Info

Publication number
DK0751785T4
DK0751785T4 DK95912261T DK95912261T DK0751785T4 DK 0751785 T4 DK0751785 T4 DK 0751785T4 DK 95912261 T DK95912261 T DK 95912261T DK 95912261 T DK95912261 T DK 95912261T DK 0751785 T4 DK0751785 T4 DK 0751785T4
Authority
DK
Denmark
Prior art keywords
thrombolytically
thrombolytically active
anticoagulants
combinations
anticoagulant
Prior art date
Application number
DK95912261T
Other languages
Danish (da)
English (en)
Other versions
DK0751785T3 (da
Inventor
Ulrich Martin
Stephan Fischer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22811809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0751785(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of DK0751785T3 publication Critical patent/DK0751785T3/da
Application granted granted Critical
Publication of DK0751785T4 publication Critical patent/DK0751785T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95912261T 1994-03-25 1995-03-22 Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf DK0751785T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/217,618 US5510330A (en) 1994-03-25 1994-03-25 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
PCT/EP1995/001061 WO1995026202A1 (en) 1994-03-25 1995-03-22 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof

Publications (2)

Publication Number Publication Date
DK0751785T3 DK0751785T3 (da) 1999-04-06
DK0751785T4 true DK0751785T4 (da) 2002-04-15

Family

ID=22811809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95912261T DK0751785T4 (da) 1994-03-25 1995-03-22 Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf

Country Status (21)

Country Link
US (1) US5510330A (no)
EP (2) EP0751785B2 (no)
JP (1) JPH09510439A (no)
KR (1) KR100366982B1 (no)
CN (1) CN1090029C (no)
AT (1) ATE167631T1 (no)
AU (1) AU702470B2 (no)
BR (1) BR9507189A (no)
CA (1) CA2186390A1 (no)
CZ (1) CZ279596A3 (no)
DE (1) DE69503120T3 (no)
DK (1) DK0751785T4 (no)
ES (1) ES2119411T5 (no)
FI (1) FI120182B (no)
MX (1) MX9603925A (no)
NO (1) NO316584B1 (no)
NZ (1) NZ282417A (no)
PL (1) PL182165B1 (no)
RU (1) RU2166326C2 (no)
UA (1) UA41398C2 (no)
WO (1) WO1995026202A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846202B2 (en) 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US20070203520A1 (en) * 1995-06-07 2007-08-30 Dennis Griffin Endovascular filter
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6750201B1 (en) * 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
US7803149B2 (en) * 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
AU2005248772B2 (en) 2004-05-17 2010-11-25 Medtronic, Inc. Point of care heparin determination system
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
AR068914A1 (es) * 2007-10-18 2009-12-16 Paion Deutschland Gmbh Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia
CN101952309A (zh) * 2007-12-21 2011-01-19 Ifxa有限公司 蛋白酶抑制剂
EP3708226A1 (en) 2014-11-03 2020-09-16 Thrombolytic Science, LLC Methods and compositions for safe and effective thrombolysis
KR101721068B1 (ko) * 2015-01-30 2017-03-29 고려대학교 산학협력단 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제
RU2622006C2 (ru) * 2015-06-15 2017-06-08 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Применение рекомбинантного штамма bacillus subtilis eo-11 вкпм в-11978 в качестве продуцента субтилизиноподобной протеиназы, вещества с тромболитическими и антикоагулянтными свойствами
CN105396127A (zh) * 2015-11-13 2016-03-16 中国人民解放军第四军医大学 一种用于急性心肌梗死的冠状动脉溶栓剂
US11154596B2 (en) 2017-06-16 2021-10-26 Thrombolytic Science, Llc Methods for thrombolysis
CN114292765B (zh) * 2021-09-24 2023-04-07 江西康之康中药科技有限公司 枯草芽孢杆菌纳豆亚种r3及其在发酵水蛭低温干燥品中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
DK43387A (da) † 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
WO1991001142A1 (en) * 1989-07-20 1991-02-07 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5189019A (en) * 1990-04-23 1993-02-23 Merck & Co., Inc. Antistasin derived anticoagulant protein
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
ATE132373T1 (de) † 1991-04-16 1996-01-15 Boehringer Mannheim Gmbh Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
ATE246000T1 (de) † 1992-06-03 2003-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung

Also Published As

Publication number Publication date
RU2166326C2 (ru) 2001-05-10
NO964007D0 (no) 1996-09-24
FI120182B (fi) 2009-07-31
EP0850648A3 (en) 2004-03-31
ES2119411T3 (es) 1998-10-01
AU1951195A (en) 1995-10-17
EP0751785B1 (en) 1998-06-24
FI963802A0 (fi) 1996-09-24
AU702470B2 (en) 1999-02-25
ATE167631T1 (de) 1998-07-15
NO964007L (no) 1996-11-25
CZ279596A3 (cs) 1998-01-14
NO316584B1 (no) 2004-03-01
EP0850648A2 (en) 1998-07-01
MX9603925A (es) 1997-04-30
ES2119411T5 (es) 2002-08-01
EP0751785B2 (en) 2001-12-19
DE69503120T2 (de) 1998-11-12
US5510330A (en) 1996-04-23
WO1995026202A1 (en) 1995-10-05
PL182165B1 (pl) 2001-11-30
UA41398C2 (uk) 2001-09-17
CA2186390A1 (en) 1995-10-05
CN1090029C (zh) 2002-09-04
BR9507189A (pt) 1997-09-09
DE69503120D1 (de) 1998-07-30
DK0751785T3 (da) 1999-04-06
NZ282417A (en) 1998-02-26
KR100366982B1 (ko) 2003-08-02
PL316449A1 (en) 1997-01-20
CN1144489A (zh) 1997-03-05
FI963802A (fi) 1996-09-24
EP0751785A1 (en) 1997-01-08
DE69503120T3 (de) 2003-08-14
JPH09510439A (ja) 1997-10-21

Similar Documents

Publication Publication Date Title
DK0751785T3 (da) Kombinationer af thrombolytisk aktive proteiner og antikoagulationsmidler samt anvendelse heraf
ES2168302T3 (es) Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e.
ES2143641T3 (es) Expresion en superficie de una enzima en la terapia genica a base de promedicamentos.
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
CY1113355T1 (el) Χρηση θεραπειας νευροτοξινης για θεραπευτικη αγωγη ουρολογικων και σχετικων διαταραχων
IT8819693A0 (it) Apparecchio atto ad operare, in modo pressoche' istantaneo, la distruzione completa dell'ago di siringhe per iniezione, subito dopo il loro impiego.
DE69524864D1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
DE69233760D1 (de) Inhibitoren der menschlichen Elastase von Neutrophilen
DE69130071D1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
ES2093607T3 (es) Rna bicatenario para la correccion de anomalias en complejos inmunes circulantes y en la funcion de los monocitos.
DE69322251D1 (de) Medizinische zusammensetzung
DE69008513D1 (de) Pharmazeutische formulierung von plasminogenaktivatorproteinen.
DK34687A (da) Laegemiddel til nasal anvendelse, dets fremstilling og anvendelse
DE69417340D1 (de) Spritze für medizinische zwecke
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
ATE143809T1 (de) Placentaextrakt und verfahren zu seiner herstellung
DK491289A (da) Modgift mod antikoaguleringsmidler
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
BR6802637U (pt) Cheque personalizado,com garantias de autenticidade, utilizavel pelos estabelecimentos de segmento farmaceutico e seu desenvolvimento operacional
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
UA31903A (uk) Спосіб лікування хронічного неспецифічного простатиту